Related Experiment Video
Updated: Aug 5, 2026

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
Published on: November 5, 2011
The Interplay of Programmed Cell Death Networks in Cardiovascular Diseases: Mechanisms and Therapeutic Opportunities
Yuruo He1,2, Xiayu Zhang1,2, Jinhui Duan1,2
1School of Medicine, Northwest University, 710069 Xi'an, Shaanxi, China.
Abstract:
Programmed cell death (PCD) encompasses multiple regulated processes, including apoptosis, pyroptosis, ferroptosis, and necroptosis. These pathways form an interconnected network that contributes to the pathogenesis of cardiovascular diseases (CVDs), including atherosclerosis and myocardial ischemia-reperfusion injury. This review highlights cell-type-specific PCD signatures, showing that endothelial cells predominantly undergo pyroptosis and ferroptosis, whereas macrophages exhibit multiple PCD modalities and complex pathological crosstalk. Moreover, the review systematically summarizes key regulatory pathways (e.g., Piezo1 [Piezo-type mechanosensitive ion channel component 1]/NLRP3 [NOD-like receptor family pyrin domain containing 3], and Nrf2 [nuclear factor erythroid 2-related factor 2]/HO-1 [heme oxygenase 1]/GPX4 [glutathione peroxidase 4]), as well as multi-target natural compounds (e.g., melatonin and Guizhitongluo Tablet) that show translational promise and advantages in modulating PCD networks. The review also provides critical insights into major bottlenecks in clinical translation, including nonspecific tissue distribution and the lack of pathway-specific biomarkers. Novel solutions, such as cardiomyocyte-specific delivery systems (e.g., CD47-targeted lipid nanoparticles) and validated biomarkers (prostaglandin-endoperoxide synthase 2 [PTGS2] for ferroptosis), are also proposed. Overall, this review advances our understanding of PCD network regulation in CVDs and proposes innovative precision therapeutic strategies that align with the evolving needs of cardiovascular translational medicine.
Insights
Programmed cell death (PCD) pathways are key in cardiovascular diseases (CVDs). This review details cell-specific PCD, regulatory networks, and natural compounds, proposing precision therapies for CVDs.
Area of Science:
- Cardiovascular Translational Medicine
- Molecular Biology
- Cell Death Pathways
Background:
- Programmed cell death (PCD) pathways, including apoptosis, pyroptosis, ferroptosis, and necroptosis, are integral to cardiovascular diseases (CVDs) like atherosclerosis and myocardial ischemia-reperfusion injury.
- Understanding cell-type-specific PCD is crucial, as endothelial cells primarily exhibit pyroptosis and ferroptosis, while macrophages display diverse PCD modalities and complex interactions.
Purpose of the Study:
- To review cell-type-specific PCD signatures in CVDs.
- To summarize key regulatory pathways and natural compounds modulating PCD networks.
- To identify clinical translation bottlenecks and propose innovative therapeutic strategies.
Main Methods:
- Systematic review of literature on PCD pathways in cardiovascular diseases.
- Analysis of cell-type-specific PCD mechanisms and regulatory networks.
- Evaluation of natural compounds and delivery systems for therapeutic potential.
Main Results:
- Endothelial cells predominantly undergo pyroptosis and ferroptosis; macrophages exhibit multiple PCD modalities.
- Key regulatory pathways (e.g., Piezo1/NLRP3, Nrf2/HO-1/GPX4) and natural compounds (melatonin, Guizhitongluo Tablet) are identified.
- Clinical translation challenges include nonspecific distribution and lack of biomarkers; solutions like targeted delivery and PTGS2 biomarker are proposed.
Conclusions:
- PCD network dysregulation significantly contributes to CVD pathogenesis.
- Targeted modulation of PCD pathways using natural compounds and advanced delivery systems offers therapeutic promise.
- Developing pathway-specific biomarkers and targeted delivery systems is essential for advancing cardiovascular translational medicine.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Cellular Injury V: Apoptosis and Autophagy
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pathophysiology of Heart Failure
The Extrinsic Apoptotic Pathway
